MarketWatch: Health Round-up
Pages: 60
Publisher: Datamonitor
Date Published: May 2006
Format: PDF
Price: $400
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 7 – Opinion: Wyeth: breast cancer prospects receive a blow…
Page 7 – Opinion: Sanofi-Aventis: Taxotere fighting to maintain blockbuster status…
Page 8 – Opinion: Merck KGaA: changing the face of cancer treatment…
Page 9 – Opinion: Novartis: heeding the shift in the cancer treatment paradigm…
Page 10 – Feature Analysis: Neoadjuvant therapy next major change in gastric cancer treatment…
Cardiovascular Update
Page 12 – News Round-up
Page 14 – Opinion: Merck/NicOx: more reinvention rather than innovation…
Page 14 – Opinion: Sanofi-Aventis/Apotex: olive branch acceptance to reduce generic threat…
Page 15 – Opinion: ZymoGenetics: rhThrombin has great potential…
Page 16 – Opinion: Boston Scientific: Guidant to rebound from product recall setbacks…
Page 17 – Opinion: Heart valve disease: a potential new market for statins…
Page 18 – Feature Analysis: PAH: market ripe for expansion as big pharma interest increases…
CNS Update
Page 21 – News Round-up
Page 23 – Opinion: ADHD: FDA debates black box warnings…
Page 24 – Feature Analysis: Tysabri poised for return to market…
IDI Update
Page 26 – News Round-up
Page 29 – Opinion: Asthma and eczema: gene discovery could be the missing link…
Page 29 – Amylin: Byetta sales set for bumpy ride…
Page 31 – Feature Analysis: TeGenero Mab causes shock side-effects in UK trial…
Page 32 – Feature Analysis: Cystic fibrosis: hope remains for a ‘miracle cure‘…
Infectious Diseases Update
Page 34 – News Round-up
Page 37 – Opinion: Human Genome Sciences: challenging the pegylated interferons…
Page 38 – Opinion: Incyte: HIV drug discontinued…
Page 38 – Opinion: Sinovac: Panflu on track in pandemic flu…
Company Spotlight
Page 40 – Schering-Plough Corporation
Biotechnology Update
Page 46 – Biotech News Round-up
Page 50 – Opinion: Novartis: higher bid to secure Chiron deal…
Company Spotlight
Page 51 – Serono SA
Index
Page 58 – Pharma companies
Page 58 – Biotech companies
Page 59 – Key drugs
